ARS Pharmaceuticals, Inc. (SPRY)
4.175
-0.06
(-1.30%)
USD |
NASDAQ |
Oct 12, 16:00
4.175
0.00 (0.00%)
After-Hours: 19:10
ARS Pharmaceuticals Free Cash Flow (Quarterly) : -60.93M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -60.93M |
| March 31, 2026 | -44.95M |
| December 31, 2025 | -43.48M |
| September 30, 2025 | -47.24M |
| June 30, 2025 | -39.64M |
| March 31, 2025 | -40.83M |
| December 31, 2024 | 41.70M |
| September 30, 2024 | -14.61M |
| June 30, 2024 | -7.317M |
| March 31, 2024 | -6.793M |
| December 31, 2023 | -17.31M |
| September 30, 2023 | -12.81M |
| June 30, 2023 | -16.70M |
| Date | Value |
|---|---|
| March 31, 2023 | -12.62M |
| December 31, 2022 | 11.88M |
| September 30, 2022 | -5.712M |
| June 30, 2022 | -6.996M |
| March 31, 2022 | -6.946M |
| December 31, 2021 | 28.66M |
| September 30, 2021 | -19.21M |
| June 30, 2021 | -14.84M |
| March 31, 2021 | -12.24M |
| December 31, 2020 | -11.34M |
| September 30, 2020 | -7.661M |
| June 30, 2020 | -5.448M |
| March 31, 2020 | -7.661M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -37.39M |
| Sionna Therapeutics, Inc. | -22.22M |
| Nektar Therapeutics | -75.86M |
| Ardelyx, Inc. | -6.412M |
| Kyntra Bio, Inc. | -3.991M |